TREM1 and biliary tract cancer: Lastly, to contextualize the role of TREM1 myeloid signature in other solid tumors in relation to therapy response, we evaluated scRNA-Seq datasets of human metastatic urothelial cancer and human biliary tract cancer undergone immune checkpoint blockade therapy, with a focus on myeloid populations36,37.